Abstract:4387 Altered expression of Bcl-2-family proteins plays central roles in apoptosis dysregulation in cancer and leukemia, promoting malignant cell expansion and contributing to chemoresistance. In this study, we compared the toxicity and efficacy in mice of natural product (+)Gossypol and its semi-synthetic derivative (+)ApoGossypol and the purified (+) and (-) enantiomers of this compound, All of these compounds were shown to bind anti-apoptotic Bcl-2-family proteins with similar affinities, based on competitive BH3 peptide displacement assays and NMR-based chemical shift mapping experiments. Comparisons of growth inhibitory and cytotoxic activity of (+)Gossypol and (+)ApoGossypol using the NCI panel of 60 tumor cell lines, as well as cultured lymphoma cell lines and primary leukemia cells suggested that Gossypol and ApoGossypol have overlapping but non-identical cytotoxic mechanisms. Daily oral dosing studies showed that mice tolerate doses of ApoGossypol 2-4-times higher than Gossypol. Hepatotoxicity and gastrointestinal toxicity represented the major adverse activities of Gossypol, with ApoGossypol far less toxic. Efficacy was tested in transgenic mice in which Bcl-2 is over-expressed in B-cells, resembling low-grade follicular lymphoma in humans. In vitro, Bcl-2-expressing B-cells from transgenic mice were more sensitive to cytotoxicity induced by ApoGossypol than Gossypol, with LD50 values of 3-5 µM and 7.5-10 µM, respectively. In vivo, using the maximum tolerated dose of Gossypol (60 µmoles/kg) for sequential daily dosing (daily x 5 days x 3 weeks), ApoGossypol displayed superior activity to Gossypol in terms of reducing splenomegaly and reducing B-cell counts in spleens of Bcl-2 transgenic mice. At higher doses (120 µmole/kg), at which ApoGossypol but not Gossypol is tolerated, ApoGossypol showed even greater in vivo activity, reducing spleen weight by 40 ± 14% (p

Effects of gossypol on the in vitro proliferation and apoptosis of murine lymphocytes

The Immunosuppressive Effect of Gossypol in Mice is Mediated by Inhibition of Lymphocyte Proliferation and by Induction of Cell Apoptosis

Effects of Gossypol on the Proliferation and Apoptosis of Jurkat T Cells

Inhibitory Effects of Gossypol on the Activation of Human T-lymphocytes Stimulated with Polyclonal Activators

Gossypol Suppresses Mouse T Lymphocytes Via Inhibition of NFκB, NFAT and AP-1 Pathways

Molecular Mechanism of Gossypol-Induced Cell Growth Inhibition and Cell Death of HT-29 Human Colon Carcinoma Cells.

Synergistic cytotoxicity of Bcl-xL inhibitor, gossypol and chemotherapeutic agents in non-Hodgkin’s lymphoma cells

Suppression of LPS-induced Inflammatory Responses by Gossypol in RAW 264.7 Cells and Mouse Models.

In Vitro and in Vivo Efficacy and Toxicity Comparison Between ApoGossypol and Gossypol, Bcl-2 Antagonists

Inhibition Of Proliferation Of Prostate Cancer Cell Line, Pc-3, In Vitro And In Vivo Using (-)-Gossypol

Effects of Gossypol on Apoptosis in Myeloid Leukemia Cells

Differential Growth Inhibition and Induction of Apoptosis by Gossypol Between Hct116 and Hct116/Bax(-/-) Colorectal Cancer Cells

Gossypol induces apoptosis in human PC-3 prostate cancer cells by modulating caspase-dependent and caspase-independent cell death pathways.

Apoptosis of multiple myeloma cells induced by gossypol acetic acid in vitro and its mechanism]

Gossypol induces apoptosis of human pancreatic cancer cells via CHOP/endoplasmic reticulum stress signaling pathway

Natural Bcl-2 inhibitor (−)– gossypol induces protective autophagy via reactive oxygen species–high mobility group box 1 pathway in Burkitt lymphoma

Biological activity in the repopulating rat spermatocyte after the withdrawal of gossypol treatment. VI. Alteration in nuclear factors for interaction with histone gene promoter.

Gossypol-Induced Differentiation in Human Leukemia HL-60 Cells.

Effect of Gynostemma Polysaccharide on Apoptosis by Dexamethasone in the spleen and thymus of mouse

Involvement of Bcl-2, Src, and ERα in Gossypol-Mediated Growth Inhibition and Apoptosis in Human Uterine Leiomyoma and Myometrial Cells

Gossypol Has Anti-Cancer Effects by Dual Targeting Mdm2 and Vegf in Human Breast Cancer